1. WHO. WHO Coronavirus Disease (COVID-19) Dashboard. See https://covid19.who.int/ (last checked 14 February 2021).
Google Scholar2. Haas, EJ , et al.Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet 2021; 397: 1819–1829.
Google Scholar | Crossref | Medline3. Vasileiou, E , et al.Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study. Lancet 2021; 397: 1646–1657.
Google Scholar | Crossref | Medline4. Figueroa, JP , et al.Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics. Lancet 2021; 397: 562–564.
Google Scholar | Crossref | Medline5. Verity, R , et al.Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis 2020; 20: 669–677.
Google Scholar | Crossref | Medline6. Rieg, S , et al.COVID-19 in-hospital mortality and mode of death in a dynamic and non-restricted tertiary care model in Germany. PLoS One 2020; 15: e0242127–e0242127.
Google Scholar | Crossref | Medline7. Onder, G, Rezza, G, Brusaferro, S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA 2020; 323: 1775–1776.
Google Scholar | Medline8. Global Health 5050. The Sex, Gender and COVID-19 Project. See https://globalhealth5050.org/the-sex-gender-and-covid-19-project/ (last checked 18 May 2020).
Google Scholar9. Docherty, AB , et al.Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: prospective observational cohort study. BMJ 2020; 369: m1985–m1985.
Google Scholar | Crossref | Medline10. Guan W, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J 2020; 55: 2000547.
Google Scholar11. Williamson, EJ , et al.Factors associated with COVID-19-related death using OpenSAFELY. Nature 2020; 584: 430–436.
Google Scholar | Crossref | Medline12. Abebe, F, Schneider, M, Asrat, B, Ambaw, F. Multimorbidity of chronic non-communicable diseases in low- and middle-income countries: a scoping review. J Comorbidity 2020; 10: 2235042X2096191–2235042X2096191.
Google Scholar | SAGE Journals13. Iaccarino, G, Grassi, G, Borghi, C, Ferri, C, Salvetti, M, Volpe, M. Age and multimorbidity predict death among COVID-19 patients: results of the SARS-RAS study of the Italian Society of Hypertension. Hypertension 2020; 76: 366–372.
Google Scholar | Crossref | Medline14. Kim, DH , et al.Age-adjusted Charlson comorbidity index score is the best predictor for severe clinical outcome in the hospitalized patients with COVID-19 infection. Medicine (Baltimore) 2021; 100: e25900–e25900.
Google Scholar | Crossref | Medline15. NHS Digital. Coronavirus (COVID-19): Shielded Patients List. See https://digital.nhs.uk/coronavirus/shielded-patient-list (last checked 5 November 2020).
Google Scholar16. Froes M, Martins B and Neves B. Comparison of multimorbidity in Covid-19 infected and general population in Portugal. BMJ 2020. medRxiv https://doi.org/10.1101/2020.07.02.20144378.
Google Scholar17. Ioannou, GN , et al.Risk factors for hospitalization, mechanical ventilation, or death among 10 131 US Veterans with SARS-CoV-2 infection. JAMA Netw Open 2020; 3: e2022310–e2022310.
Google Scholar | Crossref | Medline18. Gude-Sampedro, F , et al.Development and validation of a prognostic model based on comorbidities to predict COVID-19 severity: a population-based study. Int J Epidemiol 2021; 50: 64–74.
Google Scholar | Crossref | Medline19. PHS. Public Health Scotland. See https://www.isdscotland.org/ (last checked 5 November 2020).
Google Scholar20. PHS. electronic Data Research and Innovation Service (eDRIS). See https://www.isdscotland.org/Products-and-Services/EDRIS/ (last checked 23 July 2021).
Google Scholar21. Elixhauser, A, Steiner, C, Harris, DR, Coffey, RM. Comorbidity measures for use with administrative data. Med Care 1998; 36: 8–27.
Google Scholar | Crossref | Medline | ISI22. Metcalfe, D , et al.Coding algorithms for defining Charlson and Elixhauser co-morbidities in Read-coded databases. BMC Med Res Methodol 2019; 19: 115–115.
Google Scholar | Crossref | Medline23. Cook, TD . Advanced statistics: up with odds ratios! A case for odds ratios when outcomes are common. Acad Emerg Med 2002; 9: 1430–1434.
Google Scholar | Crossref | Medline | ISI24. Mckeigue, PM , et al.Relation of severe COVID-19 in Scotland to transmission-related factors and risk conditions eligible for shielding support: REACT-SCOT case-control study. BMC Med 2021; 19: 149–149.
Google Scholar | Crossref | Medline25. R Foundation for Statistical Computing. R: A Language and Environment for Statistical Computing. See https://www.r-project.org/ (last checked 18 May 2021).
Google Scholar26. Clift, AK , et al.Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study. BMJ 2020; 371: m3731–m3731.
Google Scholar | Crossref | Medline27. Tran, J , et al.Patterns and temporal trends of comorbidity among adult patients with incident cardiovascular disease in the UK between 2000 and 2014: a population-based cohort study. PLoS Med 2018; 15: e1002513–e1002513.
Google Scholar | Crossref | Medline28. Jani, BD , et al.Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort. BMC Med 2019; 17: 74–74.
Google Scholar | Crossref | Medline29. Peckham, H , et al.Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat Commun 2020; 11: 6317–6317.
Google Scholar | Crossref | Medline30. Clift AK, et al. Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study. BMJ 2020; 371: m3731.
Google Scholar